Nath Bio-Genes (India) Limited — Important, 11-07-2025: Updates

Nath Bio-Genes has announced a board meeting on the unaudited financial results for Q1 FY26. The company reported 15% revenue growth to ₹2802 Mn, driven by strong volume and value growth in cotton (+16% volume, +21% value) and maize (+5% volume, +24% value). Paddy value rose 9% despite a volume dip, while bajra showed stable volumes with 12% value growth. EBITDA rose 5% to ₹389 Mn, with margins steady at 14%. The Uzbekistan JV completed its first full year, supporting international expansion. Focus remains on diversifying beyond cotton, enhancing margins, and driving innovation through R&D.